Published in Arch Psychiatr Nervenkr (1970) on January 01, 1979
Psychotomimesis mediated by kappa opiate receptors. Science (1986) 3.60
Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study. Eur Arch Psychiatry Clin Neurosci (1992) 2.68
A viro-psycho-immunological disease-model of a subtype affective disorder. Pharmacopsychiatry (1998) 2.08
Socioeconomic position in early life, birth weight, childhood cognitive function, and adult mortality. A longitudinal study of Danish men born in 1953. J Epidemiol Community Health (2003) 2.05
Dopamine transporter binding in Gilles de la Tourette syndrome. J Neurol (2000) 1.79
Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression. Lancet (1997) 1.62
Social relations: network, support and relational strain. Soc Sci Med (1999) 1.43
Elevated endogenous cannabinoids in schizophrenia. Neuroreport (1999) 1.38
[A scale for the objective evaluation of the state of subjective well-being as a method for longitudinal studies]. Arzneimittelforschung (1970) 1.31
The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. Br J Psychiatry (1984) 1.19
Discrepant target detection and action monitoring in obsessive-compulsive disorder. Psychiatry Res (2001) 1.19
The myelin-pathogenesis puzzle in schizophrenia: a literature review. Mol Psychiatry (2007) 1.16
Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report. Pharmacol Biochem Behav (1983) 1.15
Different effects of nabilone and cannabidiol on binocular depth inversion in Man. Pharmacol Biochem Behav (2000) 1.13
Congenital sensory neuropathy with anhidrosis. Arch Dis Child (1968) 1.12
A comparison of two diagnostic methods. Clinical ICD diagnoses vs DSM-III and Research Diagnostic Criteria using the Diagnostic Interview Schedule (version 2). Arch Gen Psychiatry (1985) 1.10
[The importance of the endogenous cannabinoid system in various neuropsychiatric disorders]. Fortschr Neurol Psychiatr (2000) 1.09
Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis. Acta Psychiatr Scand (2004) 1.08
Possible antidepressive effects of opioids: action of buprenorphine. Ann N Y Acad Sci (1982) 1.04
Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone. Pharmacopsychiatry (2002) 1.03
Audiovisual integration of speech is disturbed in schizophrenia: an fMRI study. Schizophr Res (2009) 1.03
Evaluation of depressive states, especially in longitudinal studies. Mod Probl Pharmacopsychiatry (1974) 1.03
Viviparity and intrauterine feeding in a new holocephalan fish from the lower carboniferous of montana. Science (1980) 1.03
Estradiol levels in psychotic disorders. Psychoneuroendocrinology (2001) 1.00
High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. Neuroreport (2000) 0.99
Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5-8 year follow-up. Acta Psychiatr Scand (1988) 0.98
Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. Psychopharmacology (Berl) (1999) 0.97
Reduced binocular depth inversion in schizophrenic patients. Schizophr Res (2002) 0.96
Altered inhibition of motor responses in Tourette Syndrome and Obsessive-Compulsive Disorder. Acta Neurol Scand (2001) 0.96
Human adult bone marrow-derived somatic cells rescue vision in a rodent model of retinal degeneration. Exp Eye Res (2010) 0.95
[Primary reactions in the visual process. Thermodynamic and kinetic influence of pH on the metarhodopsin I-II transition. Proton consumption as an effect of a conformation change (author's transl)]. Z Naturforsch C (1974) 0.95
Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Arch Psychiatr Nervenkr (1970) (1980) 0.95
Stability of vancomycin in plastic syringes measured by high-performance liquid chromatography. J Clin Pharm Ther (1995) 0.94
An artificial indicator for electric phenomena in biological membranes and interfaces. Naturwissenschaften (1969) 0.94
High-flux hemodialysis--an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication. Clin Nephrol (2002) 0.93
Differential effects of emotional content on event-related potentials in word recognition memory. Neuropsychobiology (2001) 0.92
Relationship between weight gain and hypothalamic pituitary adrenal function in patients with anorexia nervosa. J Steroid Biochem (1980) 0.92
High local unemployment and increased mortality in Danish adults; results from a prospective multilevel study. Occup Environ Med (2003) 0.92
Anxiety and depression: comorbidity, psychopathology, and social functioning. Compr Psychiatry (1989) 0.91
Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry (2002) 0.91
[Disorders of premorbid social adaptation as a predictor of the 5-year prognosis of schizophrenic psychoses]. Nervenarzt (1984) 0.89
Buprenorphine and carbamazepine as a treatment for detoxification of opiate addicts with multiple drug misuse: a pilot study. Addict Biol (2000) 0.89
Cannabinoid/anandamide system and schizophrenia: is there evidence for association? Pharmacopsychiatry (1998) 0.89
Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease. Eur J Clin Invest (2006) 0.89
Visual 3D illusion: a systems-theoretical approach to psychosis. Eur Arch Psychiatry Clin Neurosci (1996) 0.89
Further evidcence for an optical response of chloroplast bulk pigments to a light induced electrical field in photosynthesis. Z Naturforsch B (1969) 0.89
Mood cycles associated with normal pressure hydrocephalus. Am J Psychiatry (1996) 0.89
Possible use of amantadine in depression. Pharmacopsychiatry (1999) 0.88
Fewer beta-endorphin expressing arcuate nucleus neurons and reduced beta-endorphinergic innervation of paraventricular neurons in schizophrenics and patients with depression. Cell Mol Biol (Noisy-le-grand) (2002) 0.88
The seeking and liking potentials of alprazolam. Am J Psychiatry (1988) 0.88
Personality in patients with affective disorders and their relatives. J Affect Disord (1998) 0.88
Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial. Bipolar Disord (2000) 0.87
An empirical comparison of diagnoses and reliabilities in ICD-10 and DSM-III-R. Eur Arch Psychiatry Clin Neurosci (1993) 0.87
[Depressive states in schizophrenic in-patients on admission and at discharge (author's transl)]. Nervenarzt (1981) 0.86
Current and historical concepts of opiate treatment in psychiatric disorders. Int Clin Psychopharmacol (1988) 0.86
Nabilone increases choreatic movements in Huntington's disease. Mov Disord (1999) 0.86
A simplified method for the histochemical localization of cardiac catecholamine-containing nerve fibers. J Histochem Cytochem (1967) 0.85
The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affect Disord (1985) 0.85
Antipsychotic effect of buprenorphine in schizophrenia. Am J Psychiatry (1987) 0.85
Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia. Biol Psychiatry (1985) 0.85
On the origin of early REM episodes in the sleep of depressed patients: a comparison of three hypotheses. Psychiatry Res (1985) 0.85
Emotion/cognition-coupling in word recognition memory of depressive patients: an event-related potential study. Psychiatry Res (2000) 0.84
Anxiety and depression in a community sample: the influence of comorbidity on social functioning. J Affect Disord (1990) 0.84
Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype? Biol Psychiatry (1982) 0.84
Inside a synesthete's head: a functional connectivity analysis with grapheme-color synesthetes. Neuropsychologia (2012) 0.83
Is there some indication from behavioral effects of endorphins for their involvement in psychiatric disorders? Adv Biochem Psychopharmacol (1978) 0.83
[Separation of different compounds in sweat, depending upon sweat flow rate]. Pflugers Arch Gesamte Physiol Menschen Tiere (1966) 0.83
The effects of tetrahydrocannabinol on the recognition of emotionally charged words: an analysis using event-related brain potentials. Neuropsychobiology (1998) 0.82
Reduced probability of smoking cessation in men with increasing number of job losses and partnership breakdowns. J Epidemiol Community Health (2010) 0.82
Disinhibited feedback as a cause of synesthesia: evidence from a functional connectivity study on auditory-visual synesthetes. Neuropsychologia (2012) 0.82
Antidepressant effects of buprenorphine. Lancet (1982) 0.82
The neural correlates of coloured music: a functional MRI investigation of auditory-visual synaesthesia. Neuropsychologia (2011) 0.82
Self-rating procedures in the evaluation of antidepressants. Psychopathology (1995) 0.81
[Body constitution, psychosis and personality]. Nervenarzt (1966) 0.81
Therapeutic effect of valproate in mania. Am J Psychiatry (1981) 0.81
Diurnal variation of mood and the cortisol rhythm in depression and normal states of mind. Eur Arch Psychiatry Neurol Sci (1987) 0.81
[Psychopathometric study of the prognostic significance of psychopathologic findings and premorbid personality for discharge of neuroleptic treated patients with schizophrenic psychoses]. Nervenarzt (1985) 0.81
Cannabis in movement disorders. Forsch Komplementarmed (1999) 0.81
MR urography: evaluation of different techniques in non-dilated tracts. Clin Radiol (2002) 0.81
Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol. Am J Psychiatry (1999) 0.81
Sleep and activity rhythms in mice: a description of circadian patterns and unexpected disruptions in sleep. Brain Res (1977) 0.80
Circadian rhythms in endogenous depression. Psychiatry Res (1985) 0.80
Neurophysiological aspects of synesthetic experience. J Neuropsychiatry Clin Neurosci (1999) 0.80
Renin-like (angiotensinogenase) activity in sweat of patients with cystic fibrosis and controls. Klin Wochenschr (1977) 0.80
[The premorbid development of patients with various forms of psychoses]. Nervenarzt (1990) 0.80
Effects of fentanyl and low doses of alcohol on neuropsychological performance in healthy subjects. Neuropsychobiology (1999) 0.80
Sleep onset REM episodes are associated with circadian parameters of body temperature. A study in depressed patients and normal controls. Biol Psychiatry (1983) 0.79
Shortened REM latency: a consequence of psychological strain? Psychophysiology (1987) 0.79
Personality factors and desynchronization of circadian rhythms. Psychosom Med (1974) 0.79
Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome. Acta Psychiatr Scand (1998) 0.79